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ABSTRACT
Objectives: While there is good evidence for
associations between short-term exposure to ozone
and a range of adverse health outcomes, the evidence
from narrative reviews for long-term exposure is
suggestive of associations with respiratory mortality
only. We conducted a systematic, quantitative
evaluation of the evidence from cohort studies,
reporting associations between long-term exposure to
ozone and mortality.
Methods: Cohort studies published in peer-reviewed
journals indexed in EMBASE and MEDLINE to
September 2015 and PubMed to October 2015 and
cited in reviews/key publications were identified via
search strings using terms relating to study design,
pollutant and health outcome. Study details and
estimate information were extracted and used to
calculate standardised effect estimates expressed as
HRs per 10 ppb increment in long-term ozone
concentrations.
Results: 14 publications from 8 cohorts presented
results for ozone and all-cause and cause-specific
mortality. We found no evidence of associations
between long-term annual O3 concentrations and the
risk of death from all causes, cardiovascular or
respiratory diseases, or lung cancer. 4 cohorts
assessed ozone concentrations measured during the
warm season. Summary HRs for cardiovascular and
respiratory causes of death derived from 3 cohorts
were 1.01 (95% CI 1.00 to 1.02) and 1.03 (95% CI
1.01 to 1.05) per 10 ppb, respectively.
Conclusions: Our quantitative review revealed a
paucity of independent studies regarding the
associations between long-term exposure to ozone and
mortality. The potential impact of climate change and
increasing anthropogenic emissions of ozone
precursors on ozone levels worldwide suggests further
studies of the long-term effects of exposure to high
ozone levels are warranted.
INTRODUCTION
Outdoor air pollution comprises a mixture of
particles and gases and has been associated
with a range of acute and chronic health
effects.1 An important component of this
mixture of pollutants is ozone (O3), a gaseous
pollutant formed by atmospheric chemical
reactions involving nitrogen oxides (NOx) and
volatile organic compound precursor gas
emissions, and driven by solar radiation and
temperature.2 3 Ozone is a highly reactive, oxi-
dative gas and the concentrations of O3 at a
given time and place are also determined by
the rate of loss through chemical reactions,
the rate of surface deposition and long-range
atmospheric transport processes which can
vary with season and meteorological condi-
tions. Climate change, as well as changes in
anthropogenic emissions of O3 precursors, is
likely to have an effect on ground-level O3 con-
centrations in the future.4 5
The highly reactive nature of O3 initiates
oxidative stress when it enters the
Strengths and limitations of this study
▪ This is the first quantitative review and
meta-analysis of cohort evidence for long-term
exposure to ozone and a range of causes of
death.
▪ Fourteen publications from eight cohorts were
identified. The majority of cohorts were from the
USA and most of these focused on selected
population subgroups.
▪ We found no evidence of associations between
long-term annual O3 concentrations and the risk
of death. Studies that used O3 concentrations
measured during the warmer months as the
exposure metric generally reported positive asso-
ciations, especially with respiratory mortality.
▪ Climate change and increasing anthropogenic
emissions of ozone precursors on ozone levels
worldwide is likely to increase the population
exposure to ozone. For the impact of these
changes on mortality to be estimated further,
cohort studies in representative populations uti-
lising comparable ozone metrics are required.
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respiratory tract.2 Epidemiological studies have demon-
strated adverse associations between short-term expos-
ure to O3 and human health including reduced
respiratory function and increased hospital admissions
and deaths from respiratory diseases.1 2 Associations
between short-term exposure to O3 and cardiovascular
mortality have also been reported; however, associations
with cardiovascular morbidity are less convincing.6
In contrast to the evidence from short-term exposure
studies, the evidence for adverse health effects associated
with long-term exposure to O3, that is, average exposure
measured over years, is mixed. The 2005 global update
to the WHO air quality guidelines7 did not ﬁnd support
for an association with mortality. In their update of
the 2006 Air Quality Criteria Document,8 the US
Environmental Protection Agency (EPA) concluded that
there was evidence suggestive of an association with
respiratory mortality but limited support for an associ-
ation with total and cardiopulmonary mortality,6 a view
endorsed by the comprehensive review of the evidence
in support of the revision of the European Union’s (EU)
air quality policies.1 While both of these reviews covered
a wide range of possible health effects, both excluded
recent large cohort studies in the UK9 and the USA.10
Furthermore, both reviews presented a narrative assess-
ment of the evidence and did not attempt a quantitative
evaluation of hazard or meta-analysis.
There is an important need to develop better concen-
tration response functions that can be used in health
impact assessments such as the Global Burden of
Disease11 and for modelling the potential ozone impacts
associated with climate change. In this review, we
present a quantitative evaluation of the evidence from
cohort studies published in the peer-reviewed literature
to October 2015, reporting associations between long-
term exposure to ozone and mortality. We also assess the
evidence stratiﬁed by cause of death, during the ‘warm
season’ and after adjustment for ﬁne particle
concentrations.
MATERIALS AND METHODS
Systematic ascertainment of cohort studies
Cohort studies published in peer-reviewed journals were
identiﬁed from searches of EMBASE (between 1974 and
week 40 2015) and MEDLINE (1946 to September week
4 2015) within Ovid. Three search strings, relating to
study design, health outcome and pollutant were used
without language restriction (provided in the online
supplementary material). Studies identiﬁed in each
search were combined and duplicates (241) removed
within Ovid.
A screening process to identify cohort studies assessing
associations between long-term exposure to ozone and
mortality was applied to the remaining 277 records. This
process used the study title and abstract to identify
potential studies for which the full paper was down-
loaded and checked. Exclusion criteria related to: (1)
article type, (2) study design, (3) outcome, (4) expos-
ure, and (5) use of individual rather than ecological cov-
ariates and further details of these criteria are provided
in the online supplementary material. A total of 253
records were deleted. The main reasons for removal
were: conference abstracts/notes, reviews, not cohort
design and no ozone data in study. The literature search-
ing and screening was undertaken by BKB.
We also conducted a separate search of PubMed (6
October 2015), undertaken by RWA and using three
similar search terms (provided in the online supplemen-
tary material). Studies identiﬁed in each PubMed search
were downloaded to Reference Manager databases
(2014 Thomson Reuters) which were then combined
and duplicates identiﬁed and removed. Two publica-
tions, additional to those returned in the Ovid searches,
were identiﬁed. One study was published subsequent to
the Ovid search date12 and the second was a reanalysis
of an existing cohort with a focus on particulate
matter.13 Finally, we included three known potentially
relevant early publications.14–16 In total, 29 cohort
studies were available for detailed evaluation to deter-
mine their inclusion in our review.
Each study was then further assessed against inclu-
sion/exclusion criteria relating to covariate adjustment
and provision of quantitative data to facilitate standard-
isation of hazard ratio (HR). Details of these exclusion/
inclusion criteria are also given in the online supple-
mentary material. Seven cohort studies did not include
adjustment for key confounders (age, sex, body mass
index, smoking and socioeconomic status) and were
excluded.17–23 Five studies14 16 24–26 did not provide
numerical values for HRs and associated 95% CIs
together with the necessary data to enable standardisa-
tion of the HR (to an increment of 10 ppb). We do,
however, note the qualitative ﬁndings from these studies.
One study of respiratory mortality27 included contribu-
tory respiratory causes of death as well as underlying
causes and was not included in our quantitative assess-
ment of the evidence because of this non-standard def-
inition of cause of death. Finally, two studies13 28
duplicated data presented in other publications15 29 and
were excluded. Hence, 14 studies met our inclusion/
exclusion criteria and were included in our quantitative
review.9 10 12 15 26 29–37 The process, together with the
numbers of studies identiﬁed at each stage, is illustrated
in ﬁgure 1.38
Data extraction and coding
For each cohort study, the following details were
extracted: (1) citation details (title, authors, date of pub-
lication, etc); (2) cohort details including study location
(country/city), study population, follow-up period(s),
confounder adjustment; (3) details of the effect esti-
mates including diagnosis, unit of measurement, con-
centration range for HR, metric description (annual
mean, etc), period of year for exposure assessment
(either all-year or ‘warm season’ according to the
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deﬁnition used in the original studies). These data were
used to characterise/describe each cohort and to calcu-
late standardised HRs and 95% conﬁdence interval (CI)
expressed per 10 ppb increase in O3 concentration.
Where necessary, estimates reported in µg/m3 were con-
verted to ppb using 1 ppb=2 µg/m3 at an ambient pres-
sure of 1 atm and a temperature of 25°C. This process
was undertaken by BKB and checked by RWA.
The STATA program ‘metan’ was used to produce forest
plots and to undertake random-effects meta-analysis
where three or more estimates from separate cohorts
were available for a speciﬁc cause of death. Where a
cohort was analysed more than once, the estimate from
the most recent study analysed, the largest sample size,
most recent exposure and follow-up periods was selected
for inclusion in the meta-analysis. This process ensured
the size and direction the HRs reported in the studies
did not inﬂuence their selection for meta-analysis, there-
fore limiting the potential for selection bias.
RESULTS
Our literature search identiﬁed 14 publications from
eight cohorts reporting HRs for ozone and mortality and
associated data to enable standardisation. Key character-
istics of each study are summarised in the online supple-
mentary material. Six cohorts focused on selected
population subgroups: Seventh Day Adventists
non-Hispanic white non-smokers (Adventist Health Study
of Smog; AHSMOG), white participants (six cities), male
veterans with diagnosed hypertension (Washington
University - Electric Power Research Institute Veterans
Cohort; WU-EPRI), and three selected occupation
cohorts: female teachers (California Teachers Study;
CTS), energy workers (Gazel) and Taiwanese civil ser-
vants. The American Cancer Society Cancer Prevention
Study II (ACS CPS II) cohort was comprised of mainly
friends, neighbours, acquaintances and relatives of volun-
teer recruiters. One study used administrative data to con-
struct a primary care cohort (CPRD). The majority of
Figure 1 Overview of ascertainment of studies.
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cohorts (5/8) and publications (11/14) were from the
USA with the ACS CPS II cohort analysed in ﬁve separate
publications. In total, 12/14 studies assessed associations
with all-cause mortality and 11/14 cause-speciﬁc mortal-
ity. Summer or peak O3 measures were assessed in 8/14
studies, and 8/14 studies reported associations adjusted
for mass of particles with a median aerodynamic diam-
eter <2.5 µm (PM2.5).
All season
Standardised effect estimates, expressed as the HR (95%
CI) per 10 ppb increase in O3, for all-cause and cause-
speciﬁc mortality are shown in the forest plot in ﬁgure 2,
and random-effects summary estimates are presented
in table 1. We found no evidence of an association
between long-term annual O3 concentrations and the
risk of death from all causes. Meta-analysis of the seven
Figure 2 RR (95% CI) of death per 10 ppb increase in long-term exposure to ozone. ACS CPS II, American Cancer Society
Cancer Prevention Study II; AHSMOG, Adventist Health Study of Smog; CTS, California Teachers Study; IHD, ischaemic heart
disease; RR, relative risk; WU-EPRI, Washington University - Electric Power Research Institute Veterans Cohort.
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HRs from the six cohorts gave a summary HR=0.96
(95% CI 0.92 to 1.00) per 10 ppb increase in O3 with evi-
dence of heterogeneity (I2=81%). Similarly, we did not
ﬁnd evidence for associations between long-term annual
O3 concentrations and deaths from cardiovascular,
ischaemic heart disease (IHD), cardiopulmonary and
respiratory diseases and lung cancer (table 1).
Warm season
O3 concentrations during the ‘warm season’ (deﬁned
either as the period April to September or July to
September or by selecting peak annual concentrations)
were reported in the ACS CPS II, CTS, WU-EPRI and
Gazel cohorts (ﬁgure 3). HRs for all-cause mortality were
generally close to unity with 95% CI that encompassed
unity. Associations for cardiopulmonary and respiratory
causes of death were more convincing with HRs in the
range 1.01–1.02 and 1.02–1.04, respectively, with lower
conﬁdence limits close to 1 other than for the French
Gazel cohort. Summary HRs derived from meta-analysis of
three or more cohorts (table 1) showed no association
with all-cause mortality but positive associations with cause-
speciﬁc mortality, respiratory in particular. The reanalysis
of the ACS CPS II cohort by Jerrett et al,26 included almost
500 000 participants across the USA and reported a HR
for respiratory mortality of 1.03 (95% CI 1.01 to 1.05) per
10 ppb increase in the average daily maximum 1 h ozone
concentrations measured between April and September.
They also considered the impact of adjusting for ambient
temperature in 90 of the 96 metropolitan statistical areas
and found no material difference in the O3 HR. Finally,
the authors assessed the shape of the concentration–
response function and found no evidence that a threshold
model speciﬁcation improved model ﬁt when compared
with a non-threshold linear model.
Adjustment for PM2.5
O3 concentrations and death from a range of diseases
adjusted for concentrations of ﬁne particles (PM2.5)
were studied in ﬁve cohorts (ACS CPS II, CTS, CPRD,
WU-EPRI and Gazel) though the bulk of the evidence
was from the ACS (ﬁgure 4). Results from these studies
do not suggest a positive association between O3 and all-
cause or cause-speciﬁc mortality, other than the single
estimate for respiratory mortality from the ACS CPS II
cohort.26
Qualitative studies
Four of the ﬁve studies that did not provide numerical
data to enable the standardisation of the HR and CIs
and hence inclusion in our quantitative review found no
evidence of statistically signiﬁcant associations with mor-
tality.14 16 25 39 The ﬁfth study reported elevated signiﬁ-
cant overall associations with mortality.24
DISCUSSION
This quantitative systematic review of the evidence for an
association between long-term exposure to O3 and an
increased risk of death identiﬁed a small literature base
dominated by US studies and the ACS CPS II cohort in
particular. We found no evidence of associations
between long-term annual O3 concentrations and the
risk of death. Studies that used O3 concentrations mea-
sured during the warmer months or peak ozone (95%
centile of daily maximum 1 h ozone) as the exposure
metric generally reported positive associations, especially
with cardiopulmonary and respiratory mortality.
Previous reviews of the health effects of long-term
exposure to O3 have provided narrative assessments of
the cohort literature as part of comprehensive assess-
ments of the epidemiological and toxicological evi-
dence.1 6 Prueitt et al40 utilised the studies identiﬁed in
the EPA review as a basis for a weight of evidence ana-
lysis for long-term exposure to O3 and cardiovascular
disease. Cohort studies published since earlier reviews7 8
were examined and revisions to previous concluding
statements considered. Our focus on a quantitative
Table 1 Meta-analytic summary estimates by cause of death
Cause of death Study citation Number of estimates HR (95% CI) I2 (%)*
All year
All causes 9 15 29 30 34 36 7† 0.96 (0.92 to 1.00) 81
Cardiovascular 9 12 32 36 5† 0.98 (0.93 to 1.04) 55
Ischaemic heart disease 9 29 36 3 1.00 (0.92 to 1.09) 72
Cardiopulmonary 15 29 30 4† 0.98 (0.90 to 1.07) 59
Respiratory 9 10 36 3 0.94 (0.81 to 1.10) 84
Lung cancer 9 15 29 30 36 6† 0.95 (0.83 to 1.08) 55
Warm season/peak ozone
All causes 29 34 36 37 4 1.00 (0.99 to 1.02) 46
Cardiovascular 26 36 37 3 1.01 (1.00 to 1.02) 0
Respiratory 26 36 37 3 1.03 (1.01 to 1.05) 0
HRs expressed per 10 ppb increase in O3.
*I2 statistic.
†Separate estimates for male and female members of AHSMOG cohort; hence, number of cohorts is one less that the number of estimates in
the meta-analysis.
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analysis of all cohorts, irrespective of publication date,
complements the narrative approach by: (1) facilitating
an assessment of the number of cohorts, the number of
published analyses and reanalyses as well as basic infor-
mation such as participant characteristics and exposure
estimation methods; (2) providing a graphical summary
of all of the evidence (in the form of a forest plot) to
enable a broad overview of the direction, magnitude
and precision of all study ﬁndings; and (3) providing,
where possible, summary HRs for use in health impact
assessment exercises. Concentration response functions
from cohort studies have been used previously in burden
and impact calculations.11 41 A disadvantage of our quan-
titative approach is that it does not reﬂect the diversity
between studies in the methods for estimating exposure
to O3, the deﬁnition of potential confounders and the
Figure 3 RR (95% CI) of death per 10 ppb increase in long-term ‘warm-season’ ozone exposure. ACS CPS II, American
Cancer Society Cancer Prevention Study II; IHD, ischaemic heart disease; RR, relative risk; WU-EPRI, Washington University -
Electric Power Research Institute Veterans Cohort.
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statistical models employed. However, the relatively small
number of independent cohorts limits the scope for
effect modiﬁcation analysis with which to explore the
relative impact of these important characteristics.
There is also a need for more details of the methods
used to determine and assign exposure estimates and
statistical models. Some studies used exposure metrics
derived from averages, or percentile values, of daily 1 h
concentrations and these may not be the most appropri-
ate measure of lower (by deﬁnition) long-term average
exposures to O3. Studies using such metrics may actually
be investigating associations with repeat exposures to the
Figure 4 RR (95% CI) of death per 10 ppb increase in long-term ozone exposure, adjusted for long-term exposure to PM2.5.
Note: For Krewski 2009, ozone increment assumed to be 10 ppb. ACS CPS II, American Cancer Society Cancer Prevention
Study II; CTS, California Teachers Study; IHD, ischaemic heart disease; WU-EPRI, Washington University - Electric Power
Research Institute Veterans Cohort; RR, relative risk; PM2.5, mass of particles with a median aerodynamic diameter less than
2.5 µm.
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highest O3 concentrations rather than investigating asso-
ciations with long-term (ie, cumulative) exposure.
However, cohort studies exploit spatial variation in indi-
vidual exposure estimates and report HRs for an incre-
ment in the O3 concentrations. Therefore, if the
statistical model assumes a linear concentration response
function (and most do), then the exact metric used is
less important and estimates can be combined in a
meta-analysis. However, the selected O3 metrics (and the
concentrations they represent) may be a source of het-
erogeneity in any meta-analysis if there is, in reality, a
non-linear concentration response function.
None-the-less, the exact deﬁnition of the exposure
metric used in each analysis has an important bearing
on the utility of study results in health impact assessment
exercises where a concentration response function is
applied to a change in pollution concentration.
Our review reveals the paucity of population-based
cohorts from which to draw substantive conclusions
about the health effects associated with the long-term
exposure to O3. One cohort comprised participants with
pre-existing medical conditions,33 and others selected
participants based on employment12 36 37 or speciﬁc par-
ticipant characteristics.30 The ACS CPS II cohort utilised
friends, neighbours, acquaintances and relatives of
volunteers and is therefore unlikely to be representative
of the US general population and the Six Cities cohort
is restricted to white participants. Only the English
cohort based on an administrative database of patients
registered with general practitioners (which is almost
universal in the UK) is population based. While studies
in selected subgroups support hazard assessment, their
ﬁndings have limited application in quantifying the risk
in the general population. The use of large, linked
administrative databases9 may enable a growth in the
number of studies reporting results which are nationally
representative. There is also a need for cohort studies
outside of the USA in order to provide a broader evi-
dence base across a range of O3 concentrations and
where relationships between O3 and co-variables of tem-
perature and other pollutants may be different. This
contrasts sharply with the large volume of epidemio-
logical evidence from time-series studies investigating
associations from short-term exposure to O3.
1 This litera-
ture incorporates a wide range of health outcomes/dis-
eases and from many regions of the world, including
stratiﬁcation by season. This evidence from short-term
exposure studies worldwide does, however, provide
support for the application of results from long-term
exposure studies in locations with cohort evidence to
regions without such evidence.11
A number of publications using the ACS CPS II
cohort have assessed associations between O3 concentra-
tions measured during the warmer months of the year
and mortality and have reported positive associations
with lower conﬁdence limits very close to 1 (ﬁgure 3).
Krewski et al29 reported results for O3 measured both
throughout the year and during April to September.
They found stronger associations for cardiopulmonary
mortality using measures of O3 during the warmer
months compared with all year (incorporating compar-
able confounder adjustment—ref. 29, table 3; 1.03 (95%
CI 1.02 to 1.04) vs 1.01 (95% CI 1.00 to 1.03) respect-
ively. Similarly, Lipfert et al33 reported a positive associ-
ation between peak exposure (95% centile of daily
maximum hourly ozone) and mortality but not with the
annual mean. However, this pattern of associations was
not observed in a similar comparison using the CTS
cohort.36
The reasons for the modest differences between HRs
estimated using warm season and all year concentrations
in the ACS CPS II study are not clear. One possibility is
that exposure measurement error varies between
seasons due to different patterns of human behaviour
(eg, time spent outdoors or window opening).42 It may
suggest a non-linear concentration response function
with larger HRs during the higher ozone concentrations
experienced during the warmer months compared with
the cooler months of the year though we note that O3
in the northern hemisphere can be high earlier in the
year. However, the ranges of ozone exposures in the
warm and all year periods were not that dissimilar, 11.7–
56.4 vs 10.4–41.1 ppb, respectively, although means (30.2
vs 22.9), medians (30.7 vs 22.5) and variances (40.9 vs
21.5) differed substantially.29 An analysis of summer
ozone concentrations using the ACS CPS II26 examined
the shape of the concentration–response function and
did not ﬁnd evidence that a threshold model speciﬁca-
tion improved model ﬁt over the linear, non-threshold
model. Ozone production during summer episodes is
closely related to temperature and solar radiation;
hence, the question of whether or not ozone associa-
tions observed during the warmer months are independ-
ent of the effects of temperature requires investigation.
Jerrett et al,26 in their analyses of summer ozone concen-
trations in the USA, found no evidence of confounding
by temperature but did report a modifying effect of tem-
perature on the ozone HRs.
Concentrations of ozone at a given time and place are
determined not just by its photochemical production,
but also the rate of chemical loss, the rate of surface
deposition, and of long-range atmospheric transport
which vary by season and meteorological conditions.
Correlations with other pollutants, including NO2 and
particles, also vary by season. Therefore, studies of the
health effects associated with long-term ozone concen-
trations should consider, if possible, the numerous com-
plexities involved including (1) seasonal patterns of
ozone production/loss; (2) whether relationships are
driven by temperature; (3) the shape of the concentra-
tion response relationship; and (4) the impact of
co-pollutants.
Climate impacts directly or indirectly on many pro-
cesses that determine the concentrations of ozone at a
particular location and time.43 44 Climate-mediated
inﬂuences on ozone include those related to emission
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ﬂuxes of ozone precursors, atmospheric chemistry, dis-
persion and transport, and loss of ozone by dry depos-
ition to vegetation. Climate change may inﬂuence future
anthropogenic emissions of ozone precursors indirectly
through mitigation and adaptation responses, such as
reduced energy demand for space heating in winter but
greater energy demand for air conditioning in summer.
Biogenic emissions of ozone precursors will also be
inﬂuenced by climate change. For those climate-
mediated processes included in model simulations to
date, modelling studies4 45 indicate that, overall, the net
impact of climate change on surface ozone is generally a
decrease in remote (low NOx) areas, but an increase in
some densely populated (high NOx) areas.
46 Human
exposure to ambient ozone may also be affected by
behavioural changes arising from adaptive strategies.47
Studies of long-term exposure to ozone may therefore
have increasing relevance in the future if concentrations
of ozone rise in densely populated urban areas.
Our quantitative review of the literature revealed a
paucity of independent, population-based studies regard-
ing the effects of long-term exposure to ozone on mor-
tality. Furthermore, the evidence from outside the USA
was very limited. However, there is a suggestion of a
modest, adverse association between long-term ozone
concentrations measured during the warmer months of
the year and cardiopulmonary and respiratory mortality.
The need for concentration response functions for
burden estimation and evaluation of impacts of climate
change will require further large, population-based
cohorts utilising comparable ozone metrics.
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